S 984 New York Senate · 2019 Regular Session

Relates to dihydropyrimidine dehydrogenase deficiency testing

Summary
Requires dihydropyrimidine dehydrogenase deficiency testing prior to fluoropyrmidine or other antimetabolite treatment; requires policies and contracts of insurance to include coverage for dihydropyrimidine dehydrogenase deficiency testing; provides for dihydropyrimidine dehydrogenase deficiency testing under the medical assistance program.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2019
Committee Review
Floor Vote
Governor
Introduced Jan 9, 2019 Last action Jan 8, 2020
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
6
Key actions
0
Committee
5
Jan 8, 2020
Committee
REFERRED TO HEALTH
upper
Jun 20, 2019
Committee
RECOMMITTED TO RULES
upper
Mar 26, 2019
Committee
COMMITTEE DISCHARGED AND COMMITTED TO RULES
upper
Jan 22, 2019
Committee
REPORTED AND COMMITTED TO FINANCE
upper
Jan 9, 2019
Committee
REFERRED TO HEALTH
upper
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.